Veracyte, Inc.
VCYT
Pozycja w akcjach
#4364
Veracyte, Inc. operates as a diagnostics company in the United States and... Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Cena akcji
$44.93
Kapitalizacja rynkowa
$3.61B
Zmiana (1 dzień)
2.57%
Zmiana (1 rok)
22.59%
Kraj
US
Handel Veracyte, Inc. (VCYT)
Kategoria
Healthcare
Zyski dla Veracyte, Inc. (VCYT)
Zyski w Jun 2026 TTM: $108.94M
Według najnowszych raportów finansowych Veracyte, Inc., obecny zysk firmy wynosi $108.94M. W roku 2023 firma osiągnęła zysk w wysokości $-76.61M, spadek w porównaniu do zysku z roku 2022, który wynosił $-36.43M. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Veracyte, Inc. od 2011 do 2026
Zyski na koniec każdego roku
| Rok | Zyski | Zmień |
|---|---|---|
| 2026 (TTM) | $108.94M | 323.17% |
| 2024 | $25.74M | -133.60% |
| 2023 | $-76.61M | 110.32% |
| 2022 | $-36.43M | -55.39% |
| 2021 | $-81.65M | 133.89% |
| 2020 | $-34.91M | 177.08% |
| 2019 | $-12.60M | -45.22% |
| 2018 | $-23.00M | -25.82% |
| 2017 | $-31.00M | -1.13% |
| 2016 | $-31.36M | -6.96% |
| 2015 | $-33.70M | 14.74% |
| 2014 | $-29.37M | 14.83% |
| 2013 | $-25.58M | 37.17% |
| 2012 | $-18.65M | 29.10% |
| 2011 | $-14.45M | 0.00% |
Zyski podobnych firm lub konkurentów
| Firma | Zyski | Różnica w zyskach | Kraj |
|---|---|---|---|
| $7.61B | 6,884.58% |
US
|
|
| $4.76B | 4,271.21% |
US
|
|
| $-252.70M | -331.96% |
US
|
|
| - | - |
CN
|
|
| $1.66B | 1,421.94% |
US
|
